Literature DB >> 19506924

Generation of a 3D model for human GABA transporter hGAT-1 using molecular modeling and investigation of the binding of GABA.

Thomas Wein1, Klaus T Wanner.   

Abstract

A three-dimensional model of the human Na(+)/Cl(-)-dependent gamma-aminobutyric acid (GABA) transporter hGAT-1 was developed by homology modeling and refined by subsequent molecular modeling using the crystal structure of a bacterial homologue leucine transporter from Aquifex aeolicus (LeuT(Aa)) as the template. Protein structure quality checks show that the resulting structure is particularly suited for the analysis of the substrate binding pocket and virtual screening experiments. Interactions of GABA and the substrate binding pocket were investigated using docking studies. The difference of 6 out of 13 substrate interacting side chains between hGAT-1 and LeuT(Aa) lead to the different substrate preference which can be explained using our three-dimensional model of hGAT-1. In particular the replacement of serine 256 and isoleucine 359 in LeuT(Aa) with glycine and threonine in hGAT-1 seems to facilitate the selection of GABA as the main substrate by changing the hydrogen bonding pattern in the active site to the amino group of the substrate. For a set of 12 compounds flexible docking experiments were performed using LigandFit in combination with the Jain scoring function. With few exceptions the obtained rank order of potency was in line with experimental data. Thus, the method can be assumed to give at least a rough estimate of the potency of the potential of GABA uptake inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506924     DOI: 10.1007/s00894-009-0520-3

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  24 in total

Review 1.  Neurotransmitter transporters in the central nervous system.

Authors:  J Masson; C Sagné; M Hamon; S El Mestikawy
Journal:  Pharmacol Rev       Date:  1999-09       Impact factor: 25.468

2.  Assessment of protein models with three-dimensional profiles.

Authors:  R Lüthy; J U Bowie; D Eisenberg
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

Review 3.  Neurotransmitter transporters: molecular function of important drug targets.

Authors:  Ulrik Gether; Peter H Andersen; Orla M Larsson; Arne Schousboe
Journal:  Trends Pharmacol Sci       Date:  2006-06-09       Impact factor: 14.819

4.  Development and validation of a modular, extensible docking program: DOCK 5.

Authors:  Demetri T Moustakas; P Therese Lang; Scott Pegg; Eric Pettersen; Irwin D Kuntz; Natasja Brooijmans; Robert C Rizzo
Journal:  J Comput Aided Mol Des       Date:  2006-12-06       Impact factor: 3.686

Review 5.  Sodium-coupled neurotransmitter transporters.

Authors:  Baruch I Kanner; Elia Zomot
Journal:  Chem Rev       Date:  2008-04-05       Impact factor: 60.622

6.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

7.  A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function.

Authors:  Thijs Beuming; Lei Shi; Jonathan A Javitch; Harel Weinstein
Journal:  Mol Pharmacol       Date:  2006-07-31       Impact factor: 4.436

8.  Molecular heterogeneity of the gamma-aminobutyric acid (GABA) transport system. Cloning of two novel high affinity GABA transporters from rat brain.

Authors:  L A Borden; K E Smith; P R Hartig; T A Branchek; R L Weinshank
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

9.  Major human gamma-aminobutyrate transporter: in silico prediction of substrate efficacy.

Authors:  Anna Palló; Akos Bencsura; László Héja; Tamás Beke; András Perczel; Julianna Kardos; Agnes Simon
Journal:  Biochem Biophys Res Commun       Date:  2007-10-29       Impact factor: 3.575

10.  Cloning and expression of a rat brain GABA transporter.

Authors:  J Guastella; N Nelson; H Nelson; L Czyzyk; S Keynan; M C Miedel; N Davidson; H A Lester; B I Kanner
Journal:  Science       Date:  1990-09-14       Impact factor: 47.728

View more
  6 in total

1.  Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures.

Authors:  Gemma L Carvill; Jacinta M McMahon; Amy Schneider; Matthew Zemel; Candace T Myers; Julia Saykally; John Nguyen; Angela Robbiano; Federico Zara; Nicola Specchio; Oriano Mecarelli; Robert L Smith; Richard J Leventer; Rikke S Møller; Marina Nikanorova; Petia Dimova; Albena Jordanova; Steven Petrou; Ingo Helbig; Pasquale Striano; Sarah Weckhuysen; Samuel F Berkovic; Ingrid E Scheffer; Heather C Mefford
Journal:  Am J Hum Genet       Date:  2015-04-09       Impact factor: 11.025

2.  Mutational mapping and modeling of the binding site for (S)-citalopram in the human serotonin transporter.

Authors:  Jacob Andersen; Lars Olsen; Kasper B Hansen; Olivier Taboureau; Flemming S Jørgensen; Anne Marie Jørgensen; Benny Bang-Andersen; Jan Egebjerg; Kristian Strømgaard; Anders S Kristensen
Journal:  J Biol Chem       Date:  2009-11-05       Impact factor: 5.157

3.  Sodium-assisted formation of binding and traverse conformations of the substrate in a neurotransmitter sodium symporter model.

Authors:  Ágnes Simon; Ákos Bencsura; László Héja; Csaba Magyar; Julianna Kardos
Journal:  Curr Drug Discov Technol       Date:  2014

4.  Homology modeling of human γ-butyric acid transporters and the binding of pro-drugs 5-aminolevulinic acid and methyl aminolevulinic acid used in photodynamic therapy.

Authors:  Yan Baglo; Mari Gabrielsen; Ingebrigt Sylte; Odrun A Gederaas
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

5.  A binding mode hypothesis of tiagabine confirms liothyronine effect on γ-aminobutyric acid transporter 1 (GAT1).

Authors:  Andreas Jurik; Barbara Zdrazil; Marion Holy; Thomas Stockner; Harald H Sitte; Gerhard F Ecker
Journal:  J Med Chem       Date:  2015-02-26       Impact factor: 8.039

Review 6.  Structure, Function, and Modulation of γ-Aminobutyric Acid Transporter 1 (GAT1) in Neurological Disorders: A Pharmacoinformatic Prospective.

Authors:  Sadia Zafar; Ishrat Jabeen
Journal:  Front Chem       Date:  2018-09-11       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.